[Theranostics in 2020: Neuroendocrine tumors]

Magy Onkol. 2020 Jun 10;64(2):119-130. Epub 2020 Feb 15.
[Article in Hungarian]

Abstract

This article presents the diagnostic and therapeutic nuclear medicine methods for neuroendocrine tumors in accordance with current guidelines. The paper begins with a general characterization of neuroendocrine tumors, followed by a broad introduction to laboratory and imaging diagnostic techniques, and a detailed discussion of peptide receptor radionuclide therapy and meta-iodobenzylguanidine treatment. Finally, the article provides an insight into current research and future developments.

MeSH terms

  • 3-Iodobenzylguanidine
  • Forecasting
  • Humans
  • Neuroendocrine Tumors* / diagnostic imaging
  • Theranostic Nanomedicine*

Substances

  • 3-Iodobenzylguanidine